Faculty Directory
Our Faculty has grown to over 100 exceptional researchers focused in a variety of research specialties
Our group generates and analyzes multi-omics data to improve our current knowledge of cancer's etiology, discover new biomarkers and facilitate personalized cancer treatments
The lab studies molecular alterations in cancer and the clinical importance of these changes with a focus on the tumour immune microenvironment.
Our research investigates the underlying genetic and environmental determinants of human disease, with a focus on aging, cancer, chronic diseases, and infectious agents
The Campbell Lab is a group of data scientists working at the interface of statistics, machine learning, and translational biomedicine.
We utilize zebrafish precision models of disease to discover novel genetic causes, pathogenic mechanisms and therapies; a current focus is scoliosis.
Our research aims to develop treatments for rare inherited diseases using novel gene editing and gene modulation technologies.
The Costain Lab is focused on discovering and characterizing new genetic diseases that impact children.
Mechanisms of cell fate specification, epigenetic inheritance, paediatric diseases models such as cerebral cavernous malformation and neuroblastoma.
We use zebrafish and human stem cell models to study genetic liver disorders and novel mendelian diseases.
Our lab is interested in applying stem cell biology to the study of brain cancer.
Our lab seeks to understand the pathogenic mechanisms of and develop therapies for childhood muscle diseases.
We study how cells maintain the integrity genome and how this process is dysregulated in cancer, aging and genetic disorders.
I am interested in studying the human proteins that have the fewest publications, because that is where I believe the most new biology can be found.
Our research focuses on using precision zebrafish models of human cancer to understand mechanisms related to tumor growth, relapse, and metastasis
Studying cancer at the single-cell level, analyzing tumour cells and their microenvironments using cutting-edge imaging techniques
The Kalish Lab seeks to understand how pregnancy and early life experience shape neurodevelopment and plasticity.
How stem cells build and maintain the brain and discovering drugs and growth factors that mobilize these cells to repair the injured brain and skin.
Our lab investigates the gut stem microenvironment in development, stem cell homeostasis and disease such as inflammation and cancer.
We use mouse models and human genetic analysis to probe the underlying molecular basis 7q11.23 copy number variation disorders.
Our laboratory focuses on studying the molecular mechanisms underlying neurodegenerative diseases with the aim of developing therapeutic approaches.
Elucidating molecular mechanisms of disease-causing expansions of tandem repeated DNAs with the goal of therapeutically targeting this mutation.
Modelling human heart development and diseases with pluripotent stem cells with the overarching goal to develop new therapies.
The Reimand lab focuses on computational biology and cancer research. We conduct integrative multi-omics analyses and develop computational methods.
New Technologies to Identify Novel Drug Candidates, Novel Infectious Disease Drug Targets, C. elegans Models of Disease, Xenobiotic Response Circuitry
Genome sequencing, annotation, medical interpretation and discovery. Studies of genomic architecture in autism, diagnostics and treatment.
We focus on the regulation of mitochondrial gene expression and the impact of mitochondrial mutations in common and rare diseases.
The main goal of our lab is to understand how interactions among membrane proteins produce either healthy or diseased cells
Developmental and stem cell biology of the brain, retina and pancreas; the neurobiology of motivation; and learning and memory genes in C.elegans.
We are a research group interested in genome regulation and human disease and comparative genomics to study evolution and human disease.
We are interested in understanding how genetic and epigenetic variations contribute to human health, with a focus on neurodevelopmental and neurological disorders.